TUESDAY, Sept. 10, 2024 -- For patients with severe asthma with an eosinophilic phenotype, depemokimab reduces the annualized rate of exacerbations,...
Vous n'êtes pas connecté
MONDAY, July 8, 2024 -- Second- or third-line treatment with tisotumab vedotin is efficacious for patients with recurrent cervical cancer, according to a study published in the July 4 issue of the New England Journal of Medicine. Ignace Vergote...
TUESDAY, Sept. 10, 2024 -- For patients with severe asthma with an eosinophilic phenotype, depemokimab reduces the annualized rate of exacerbations,...
MONDAY, Sept. 9, 2024 -- Cancer diagnosis is associated with an increased risk for psychological illness and cardiovascular disease among...
A new study has shown that eating more fruits and vegetables can significantly lower blood pressure and improve heart and kidney health in people with...
WEDNESDAY, Sept. 11, 2024 -- Conditions offering alternative explanations for lung cancer symptoms are associated with increased diagnostic intervals,...
WEDNESDAY, Aug. 28, 2024 -- Adult patients with inflammatory bowel disease (IBD) and respiratory syncytial virus (RSV) infection have an increased...
THURSDAY, Sept. 5, 2024 -- The risk for 30-day readmission is high for adult sepsis survivors discharged to skilled nursing facilities, home health...
MONDAY, Sept. 9, 2024 -- In a clinical practice guideline issued by the American College of Gastroenterology and published in the September issue of...
A new study reveals a potential breakthrough in combating aggressive prostate cancer Researchers from Flinders University and the University of South...
FRIDAY, Sept. 6, 2024 -- The risk for lung cancer is high in patients with rheumatoid arthritis (RA) and pulmonary complications, according to a study...
WEDNESDAY, Sept. 4, 2024 -- Efforts to rule out bladder tumors and tuberculosis are still essential in the follow-up of patients with suspected...